Aptamers Market Size, Share, Growth, and Industry Growth by Type (DNA-Based Aptamers and RNA-Based Aptamers), By Application (Research Development and Drug Discovery) Regional Forecast (2022-2027)

• 
• Request a Free sample to learn more about this report

REPORT OVERVIEW

The global aptamers market size was USD 61 million in 2020. The global COVID-19 pandemic has been unprecedented and staggering, with aptamers experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. As per our research, the market is projected to touch USD 144.3 million by 2027, exhibiting a CAGR of 12.5% during the forecast period.  The sudden spike in CAGR is attributable to demand returning to pre-pandemic levels once the pandemic is over.

Aptamers are peptide molecules that are bound to a specific target molecule. They are single-stranded RNA or DNA and short molecules that can bind. They are usually created by selecting them from a large random sequence pool. They take a variety of shapes owing to their tendency to form helices and single stranded loops. They are generated quickly and are characterized by protein and specific detection that can be used as pharmaceutical leads. They are extremely versatile in nature as they choose who they bind very carefully.   

The increasing growth for such product is attributed to increase in number of clinical trials and for development of related therapeutics. The growing awareness regarding them due to the advantages compared to antibodies and also investments in the R&D activities. Due to the rise of chronic and rare diseases there has been growing preferences for such therapeutics and diagnostics. The demand is expected to grow owing to technological advancements regarding selection process and synthesis.  

COVID-19 Impact: Various R&D Activities during Pandemic to Impel Market Development  

The effects of the COVID-19 pandemic are already being felt on a global level. In 2020, COVID-19 has had a negative impact on many markets. Several countries went into lockdown. With the sudden pandemic, all kinds of businesses observed disruptions. With many restrictions in the pandemic, different types of markets were negatively impacted. The outbreak of COVID-19 pandemic increased the burden on healthcare systems and pharmaceutical industry globally. During the pandemic, there were increase in R&D process and activities where companies teamed up and partnered up with many pharmaceutical companies and academic institutes. Companies successfully developed aptamers based diagnostic kits for COVID-19 pandemic. 

LATEST TRENDS

"Capital Ventures in Research to Propel Market Demand"

Growing capital funding ventures for research to increase the growth of the global aptamers market. Many companies have identified the potential and applications for therapeutic and diagnostic. They are now ready to expand their market position by expanding their offerings. Therefore, increasing venture capital is expected to pose an opportunity to drive the market. Research conducted from such funding is expected to focus on development activities in pharmaceutical and biotechnology sectors by introducing various pharmaceutical drugs. Such new capital funding ventures are expected to propel the market growth by posing new opportunities.

SEGMENTATION

• 
• Request a Free sample to learn more about this report

• By Type

According to type; the market is divided into DNA-based aptamers and RNA-based aptamers.

DNA-based aptamers is the leading part of the type segment. This segment is expected to grow owing to increasing initiatives in research and development.   

• By Application

Based on the application; the market is divided into research and development and drug discovery.

DRIVING FACTORS

"Rising Awareness of Benefits to Drive Market Growth"

The global aptamers market growth is anticipated to rise due rising awareness of advantages of the product. They have the ability to bond to small molecules and dyes and can be easily used in diagnostic kits. This is expected to ensure its applications in both diagnostic and therapeutic tests. They can also bind to large molecules as they are majorly from proteins making them easier to discover biomarkers and diagnostic kits. This has led to a growing number of academic research and investigations to examine the potential. The rising awareness regarding the benefits is projected to drive demand for the market.

"Advantages Over Antibodies to Surge Market Demand"

The demand is rising quickly when compared to antibodies. The use of aptamer has many advantages over antibodies such as superior or equal affinity and choosing specific target, is of smaller size, easy modification, and better stability, immobilization, and higher reproducibility. In addition, laboratories and research institutes are also conducting clinical testing to explore the benefits over antibodies. This is expected to propel the market growth and development.

RESTRAINING FACTORS

"Low Affinity to Hinder Market Growth"

There are a number of factors that can push the growth of the market. Restraining factors such as low affinity is expected to act as a restraint for this market. Even if the product can target a wide variety of molecules, studies have proved that they don’t possess high affinities for all types of molecules. Additionally, many of them have failed safety and efficacy standards in the studies and tests. These factors are expected to reduce the demand for the product in the market.

REGIONAL INSIGHTS

• 
• Request a Free sample to learn more about this report

"North America to Govern Market Due Owing to Technological Advancements "

North America holds the largest part of the global aptamers market share due to strong factors such as technological advancements and increasing R&D activities. The U.S. is the leading country of the region due to governments initiatives that are favorable, advanced technologies that are funded, and also a rise in the number of research laboratories. The region is also characterized by high investments and support in development.

Asia Pacific is also expected to have considerable growth owing to the presence of key players in the region. The growth is attributed to increasing R&D activities, rise of drug discovery, and development of products.

KEY INDUSTRY PLAYERS

"Key Players to Boost Demand Leading to Market Growth"

The report delivers information about the list of market players and their working in the industry. The information is collected and reported with proper research, technological developments, acquisitions, mergers, expanding production lines, and partnerships. Other aspects examined for the market includes companies producing and introducing new products, regions they conduct their operations in, automation, technology adoption, generating the most revenue, and making a difference with their products.

List of Market Players Profiled

• TriLink BioTechnologies (U.S.)
• AptaBharat (India)
• SomaLogic (U.S.)
• AM Biotechnologies (U.S.)
• Aptamer Sciences (South Korea)
• Base Pair Biotechnologies (U.S.)
• Aptamer Group (U.K.)
• Aptagen (U.S.)
• Aptus Biotech (Spain)
• NeoVentures Biotechnology (Canada)
• Ray Biotech (U.S.)
• Vivonics (U.S.)

INDUSTRY DEVELOPMENT

• November 2021: Achiko, a health tech company that develops technologies that have diagnostic testing for COVID-19 and other pathogenic diseases are affordable and rapid. The company has announced the development of a DNA aptamer-based dengue fever diagnostic test.   

REPORT COVERAGE

This research profiles a report with widespread studies that take into an explanation of the firms that exist in the market affecting the forecasting period. With detailed studies done, it also offers a comprehensive analysis by examining the factors like segmentation, opportunities, industrial developments, trends, growth, size, share, restraints, etc. This analysis is subject to alteration if the key players and probable analysis of market dynamics changes.